Jim Kling is a Medical Writer and Journalist at MDEdge. He specializes in science and medical writing, contributing to a variety of publications including Gastroenterology & Endoscopy News, Targeted Oncology, and Medscape. His work has been featured in notable outlets such as RamaOnHealthcare, showcasing his expertise in the medical field.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Not enough data
Jim Kling's coverage primarily focuses on healthcare and pharmaceutical topics, with an emphasis on scientific research. He frequently cites data in his articles, indicating a preference for evidence-based information.
To effectively reach out to Jim Kling, consider providing him with access to recent and relevant scientific studies or clinical trial data related to the topics he covers. Experts who can interpret complex medical data and provide insightful analysis would likely be valued sources for his articles.
Given the specificity of his article titles, pitching new developments in neurology, myasthenia gravis treatments, breast cancer therapies or advancements in artificial intelligence within these medical fields could capture Jim Kling's interest.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Study findings indicate that ‘the impact of cigarette smoking on fracture risk is reversible.’
A 12-month dance intervention requiring just two sessions a week improves strength and cognition and reduces falls.
Jim Kling September 19, 2025 SEATTLE — Researchers who have established the level of bone mineral density (BMD) change that can
Researchers hope that changes to total hip BMD will get approval from the FDA as a surrogate endpoint for clinical trials of investigational anti-osteoporosis drugs.
Jim Kling October 27, 2025 The drug colchicine may reduce cardiovascular outcomes among patients with gout, based on a range of
Jim Kling October 27, 2025 In patients with gout , a novel prediction tool that relies on weight and creatinine clearance successfully
Dose prediction tool could streamline treat-to-target strategy of achieving urate levels below 6 mg/dL.
Jim Kling October 29, 2025 The conduct of clinical trials poses ethical questions for any medical condition, and gout is no exception, including some of its own peculiarities.
The ability to predict gout flares could enable prophylactic treatment.
Human studies suggest protective associations, but clinical benefit remains elusive.
